EUVIMEDEUVIMED entdecken
Crossref

Lactate‐Depleting Engineered Probiotics Remodel the Tumor Microenvironment and Enhance PD‐1 Blockade

Jing Zhang iD, Qiushuang Zhang, Yuhan Liu, Yicong Dai iD, Xucong Teng iD, Jinghong Li iD

Advanced Healthcare Materials · 2026-07 · 15 (25)

DOI: 10.1002/adhm.71316 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 01.06.2026. Verfasst von Jing Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical Engineering, College of Life Sciences, Qingdao University, Qingdao, China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Probiotics, Lactic Acid, Programmed Cell Death 1 Receptor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: Natural Science Foundation of China, Natural Science Foundation of Anhui Province, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High lactate concentrations in the tumor microenvironment (TME) suppress antitumoral immunity. Although modulating intratumoral lactate is a promising strategy, tumor‐targeted interventions remain limited. Here, we developed an engineered probiotic, Lac‐EcN, capable of targeted lactate consumption within the TME. Lac‐EcN reduces intratumoral lactate levels by over 60% and alleviates tumor acidosis, accompanied by reversal of aberrant NFAT1 nuclear translocation in Tregs and restoration of effector molecule production by cytotoxic T cells. In B16‐F10 melanoma and MC‐38 colorectal carcinoma models, Lac‐EcN combined with anti‐PD‐1 improves tumor inhibition and extends survival. These results position engineered probiotics as a platform for targeted metabolic intervention in the TME, integrating metabolic reprogramming with immune checkpoint blockade.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentProbioticsLactic AcidProgrammed Cell Death 1 ReceptorImmune Checkpoint InhibitorsAnimalsMiceCell Line, TumorMice, Inbred C57BLHumansMelanoma, ExperimentalColorectal Neoplasms

Stichwörter der Autor:innen

cancer immunotherapyengineered probioticslactate metabolism, PD‐1 blockadetumor microenvironment

Substanzen

Lactic AcidProgrammed Cell Death 1 ReceptorImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Institute of Biomedical Engineering, College of Life Sciences, Qingdao University, Qingdao, China.
  • New Cornerstone Science Laboratory, Department of Chemistry, Key Laboratory of Bioorganic Phosphorus Chemistry & Chemical Biology, Tsinghua University, Beijing, China.
  • Center for BioAnalytical Chemistry, Hefei National Laboratory of Physical Science at Microscale, University of Science and Technology of China, Hefei, China.
  • Beijing Life Science Academy, Beijing, China.

ORCID-Profile: Jing Zhang, Yicong Dai, Xucong Teng, Jinghong Li

Förderung

  • Natural Science Foundation of China
  • Natural Science Foundation of Anhui Province
  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, J., Zhang, Q., Liu, Y., Dai, Y., Teng, X., & Li, J. (2026). Lactate‐Depleting Engineered Probiotics Remodel the Tumor Microenvironment and Enhance PD‐1 Blockade. Advanced Healthcare Materials, 15(25). https://doi.org/10.1002/adhm.71316

Vancouver

Zhang J, Zhang Q, Liu Y, Dai Y, Teng X, Li J. Lactate‐Depleting Engineered Probiotics Remodel the Tumor Microenvironment and Enhance PD‐1 Blockade. Advanced Healthcare Materials. 2026;15(25). doi:10.1002/adhm.71316

BibTeX
@article{Zhang2026,
  author = {Zhang, Jing and Zhang, Qiushuang and Liu, Yuhan and Dai, Yicong and Teng, Xucong and Li, Jinghong},
  title = {Lactate‐Depleting Engineered Probiotics Remodel the Tumor Microenvironment and Enhance PD‐1 Blockade},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  volume = {15},
  number = {25},
  doi = {10.1002/adhm.71316}
}
Kostenlos starten →